Evidence map›Paper›PMID 39525030›Full record

ArticleTranslational cancer research2024

The role of SEC14L4 in esophageal squamous cell cancer: insights into clinical relevance and molecular pathways.

An Wang, Youbo Wang, Yanhui Chen, Posum Wan, Anwaar Saeed, Qinyun Ma, Xiaofeng Chen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Translational cancer research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

An Wang *Department of Thoracic Surgery, Huashan Hospital, Fudan University, Shanghai, China.
Youbo Wang *Department of Thoracic Surgery, Huashan Hospital, Fudan University, Shanghai, China.
Yanhui Chen *Department of Nursing, Huashan Hospital, Fudan University, Shanghai, China.
Posum WanDepartment of Thoracic Surgery, Huashan Hospital, Fudan University, Shanghai, China.
Anwaar SaeedDivision of Hematology & Oncology, Department of Medicine, University of Pittsburgh Medical Center (UPMC), Pittsburgh, PA, USA.
Qinyun MaDepartment of Thoracic Surgery, Huashan Hospital, Fudan University, Shanghai, China.ORCID https://orcid.org/0000-0002-0867-2114
Xiaofeng ChenDepartment of Thoracic Surgery, Huashan Hospital, Fudan University, Shanghai, China.ORCID https://orcid.org/0000-0003-1333-6649

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Esophageal squamous cell cancer (ESCC) is the most common type of esophageal cancer. This study aimed to elucidate the role of Saccharomyces cerevisiae-like 4 ( Methods: To elucidate the role of Results: Conclusions: High expression of SEC14L4 is associated with poorer clinical outcomes, highlighting its potential as a therapeutic target and suggesting its involvement in the molecular mechanisms underlying ESCC.

Indexed as

drug resistanceesophageal squamous cell cancer (ESCC)prognosisSaccharomyces cerevisiae-like 4 (SEC14L4)

Identifiers

PMID39525030
PMCPMC11543032

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.